Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1

André F.Ciruelos E.M.Juric D.Loibl S.Campone M.Mayer I.A.Rubovszky G.Yamashita T.Kaufman B.YEN-SHEN LUInoue K.Pápai Z.Takahashi M.Ghaznawi F.Mills D.Kaper M.Miller M.Conte P.F.Iwata H.Rugo H.S.2021-03-102021-03-1020210923-7534https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098218091&doi=10.1016%2fj.annonc.2020.11.011&partnerID=40&md5=6a54290a1f0b8790641517660593066ehttps://scholars.lib.ntu.edu.tw/handle/123456789/551327[SDGs]SDG1[SDGs]SDG3Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1journal article10.1016/j.annonc.2020.11.011332460212-s2.0-85098218091